Acima Private Wealth, LLC Eli Lilly & CO Transaction History

Acima Private Wealth, LLC

$298 Billion
Q3 2024

A detailed history of Acima Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Acima Private Wealth, LLC holds 263 shares of LLY stock, worth $209,261. This represents 0.08% of its overall portfolio holdings.

Number of Shares

263

Previous 357 26.33%

Holding current value

$209,261

Previous $323 Million 27.91%

% of portfolio

0.08%

Previous 0.12%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $72,581 - $90,241	-94 Reduced 26.33%	263 $233 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $50,016 - $62,723	-69 Reduced 16.2%	357 $323 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $1,776 - $2,376	-3 Reduced 0.7%	426 $331 Million
Q4 2023 Feb 28, 2024	SELL	$525.19 - $619.13 $115,016 - $135,589	-219 Reduced 33.8%	429 $250 Million
Q1 2023 Feb 28, 2024	BUY	$310.63 - $364.82 $10,561 - $12,403	34 Added 5.54%	648 $223 Million
Q2 2022 Feb 28, 2024	SELL	$278.73 - $327.27 $14,493 - $17,018	-52 Reduced 7.81%	614 $199 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $31,917 - $39,665	-136 Reduced 16.96%	666 $191,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $6,869 - $8,454	-31 Reduced 3.72%	802 $185,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $6,319 - $8,173	-35 Reduced 4.03%	833 $191,000
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $73,122 - $94,660	-445 Reduced 33.89%	868 $162,000
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $61,265 - $75,882	573 Added 77.43%	1,313 $173,000
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $10,679 - $11,616	100 Added 15.63%	740 $82,000
Q1 2019 May 06, 2019	BUY	$111.31 - $131.02 $71,238 - $83,852	640 New	640 $83,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acima Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acima Private Wealth, LLC with notifications on news.

Account

Acima Private Wealth, LLC Eli Lilly & CO Transaction History